Tindamax

   
Google
 
Web NewDrugInformation.com

Tindamax


Drug - Tindamax
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Tinidazole
Multiple ingredients are in alphabetical order.

Strength - 250MG
The potency of the active ingredient(s), Tinidazole. May repeat for multiple part products.

Applicant - PRESUTTI LABS
The firm name holding legal responsibility for Tindamax. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021618
The FDA assigned number to Tindamax. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Tindamax. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 17, 2004
The date Tindamax was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Tindamax. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tindamax is in. Format is RX, OTC, DISCN.

Applicant Full Name - Presutti Laboratories
The full name of the firm holding legal responsibility for the new application of Tindamax.

Tindamax